SevaMob
SevaMob is an AI-enabled B2B healthcare platform that combines nine proprietary point-of-care AI diagnostic modules with tele-health and asset-lite popup clinics to deliver last-mile primary care to employers, NGOs, hospitals, pharma, insurers and government.
- Company typePrivate
- Founded2013
- HeadquartersDecatur, United States
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What SevaMob does
SevaMob is a B2B AI-enabled healthcare platform founded in 2013, operating from Lucknow, India and Decatur, Georgia, USA. The company sells proprietary point-of-care AI screening tools combined with tele-health and asset-lite popup clinics to deliver last-mile primary healthcare in underserved Tier 1, 2, 3 and rural areas. Its core product, Sevamob AI, comprises nine modules (Symptoms, Diet, Lab Report, Medical Evaluation, Sputum, Blood, Vision, Xray and Campaign AI) built on deep learning, machine learning, and computer vision, engineered to operate offline in low-resource settings with minimal training. A developer API under the Seva360 brand allows third-party integration of blood, vision, sputum and xray image analysis into web or mobile applications.
The company monetizes through software licensing of its AI modules (subscription/recurring) and managed-services health outcome delivery, targeting enterprise B2B customers across six segments: employers, NGOs, hospitals and clinics, pharmaceutical companies, health insurance, and local government. Documented outcomes include up to 50% lower primary care cost, up to 67% lower nutrition intervention cost, 190,000+ COVID consults, 74,000+ vaccinations, and an 88.85% COVID recovery rate. The founder-led, 51–100-employee organization has closed six funding rounds between 2012 and 2022 (amounts undisclosed) with investors including ImpactAssets, MassChallenge, VilCap Investments, D3 Jubilee, Caspian Debt and SAMRIDH Healthcare, and operates named partnerships with Apollo Telemedicine, Plan India and SEIL Energy India.
SevaMob firmographics
Firmographics- Name
- SevaMob
- Legal name
- Sevamob
- Website
- https://sevamob.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- SevaMob is an AI-enabled B2B healthcare platform that combines nine proprietary point-of-care AI diagnostic modules with tele-health and asset-lite popup clinics to deliver last-mile primary care to employers, NGOs, hospitals, pharma, insurers and government.
- Ownership category
- akta.pro rank
SevaMob industry classification
Industry- Product category
- AI Healthcare Platform
- NAICS
- All Other Outpatient Care Centers (621498), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Health Services (8000), Services-Computer Programming Services (7371)
- akta.pro primary industry
- Chronic Condition Management & Remote Monitoring (e.g., diabetes, HTN) (HLALADAD)
Keywords
Where SevaMob is headquartered
LocationHeadquarters
- HQ city
- Decatur
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
SevaMob business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Software Licensing: Monetization via software licensing of AI-based point-of-care triage, screening and consultation tools
- Health Outcome Delivery: Revenue from delivering health outcomes via tele-health and asset-lite popup clinics
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
SevaMob product offering
Product offeringCore offering
SevaMob provides an AI-enabled healthcare platform that combines proprietary point-of-care AI screening modules (Symptoms AI, Diet AI, Lab Report AI, Medical Evaluation AI, Blood AI, Vision AI, Sputum AI, Xray AI, Campaign AI) with tele-health consultations and asset-lite popup clinics to deliver primary health outcomes at the last mile. The company licenses its AI platform to B2B customers including employers, NGOs, hospitals, pharma companies, health insurers, and local government, and offers a Developer API (Seva360) for integration into web or mobile applications. Solutions are designed to work offline in low-resource settings with minimal training required for health workers.
Product overview
SevaMob is an AI-enabled healthcare platform consisting of two integrated components: (1) Sevamob AI - a proprietary AI engine with multiple modules including Campaign AI, Symptoms AI, Diet AI, Lab Report AI, Medical Evaluation AI, Sputum AI, Blood AI, Vision AI, and Xray AI for point-of-care triage, screening and consultation; and (2) Seva360 - a developer API and deployment platform for integrating AI capabilities. The platform delivers health outcomes via tele-health and asset-lite popup clinics across interventions including general health, nutrition, tuberculosis, vision, cardiometabolic, cancer, ENT, and Covid care. B2B customers include employers, NGOs, hospitals/clinics, pharma, health insurance and local government.
Differentiator
Problem solved
Functional benefit
Brands
- Seva360: A platform referenced as a separate web property for integrating Sevamob AI in web or mobile applications via REST API.
- Sevamob AI
Products and services
- Sevamob AI AI-assisted disease management platform using proprietary deep learning, machine learning and computer vision for rapid, offline point-of-care screening in low-resource settings. Includes multiple AI modules for symptoms analysis, lab reports, diet recommendations, and medical imaging (blood, vision, sputum, X-ray). Sold to enterprise B2B customers including employers, NGOs, hospitals/clinics, pharma, health insurers, and local government.
- Seva360 Developer API and deployment platform for embedding Sevamob AI capabilities (blood, vision, sputum and X-ray image analysis) into third-party web or mobile applications via REST API.
- General Health Intervention Service program including online and offline consultation, basic point-of-care diagnostics and medicines for general seasonal and hygiene-related diseases. Delivered in Tier 1, 2, 3 and rural areas with up to 50% cost reduction in general health intervention.
- Nutrition Intervention Point-of-care screening for BMI and anemia, prediction of multivitamin/mineral deficiencies with diet recommendations, behavioral counseling and supplements delivery, leveraging Diet AI to enable nurse-led dietitian-level assessments at up to 67% lower delivery cost.
- Tuberculosis Intervention Point-of-care screening for active TB cases, consultation and treatment compliance using Symptoms AI, Sputum AI and Xray AI for improved case identification versus manual sputum analysis or mantoux test.
- Vision Intervention Consultation, vision acuity screening, diabetic retinopathy and cataract screening using Vision AI, prescription glasses and referrals, with up to 25% improvement in vision issues in select groups.
- Cardiometabolic Intervention Consultation, point-of-care testing, counseling and medicine delivery for diabetes and hypertension management in underserved last-mile areas, with up to 10% discount on MRP for medicine delivery.
- Cancer Intervention Breast, prostate and cervical cancer screening, counseling and referrals delivered at the last mile for convenient access in underserved areas.
- ENT Intervention Consultation, hearing screening, hearing aids and ENT care referrals at the last mile, with up to 5% improvement in hearing issues in select groups.
- Covid Intervention Online and offline consultation, onsite screening, treatment for asymptomatic, mild and moderate patients, and vaccination support. Delivered 190,000+ Covid consults and 74,000+ vaccinations with an 88.85% recovery rate.
Quantifiable outcome
- Upto 50% reduction in cost of general health intervention
- +4 more outcomes
Companies that use SevaMob
Customer profileNamed customers3 records
Segments6 records
Ideal customer profiles7 records
SevaMob technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability8 records
Feature10 records
SevaMob partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Apollo Telemedicine Networking FoundationcorePartnership for health awareness camps and medical outreach initiatives. Collaborated on programs across 24 anganwadi centres reaching nearly 1,300 beneficiaries across Andhra Pradesh and Odisha.
- Plan IndiacorePartnership for CSR health initiatives including health awareness camps and medical outreach programs on World Health Day across Nellore district.
- KPMGminorDr Niti Pall, Medical Director of KPMG global healthcare practice, serves as advisor helping with strategic partnerships.
Scale indicators10 records
Recent moves6 records
Expansion highlights6 records
SevaMob competitors and assessment
Company assessmentDirect peers
- Qure.ai: India- and US-based AI medical-imaging company specializing in chest X-ray, CT, and head CT triage. Direct peer because SevaMob's Xray AI module for TB screening competes head-on with Qure.ai's qXR product on the same clinical use case and customer base (public hospitals, TB programs).
- Tricog Health: Indian AI-health company offering cloud-connected ECG diagnosis for cardiac conditions at point of care, focused on underserved and rural India. Direct peer given its AI-at-point-of-care model, vertical specialization, and last-mile delivery into Tier 1–3 markets — closely paralleling SevaMob's intervention-based approach.
- Niramai Health Analytix: Indian AI-health startup offering non-invasive breast cancer screening using thermal imaging and AI, targeting rural and semi-urban populations. Direct peer because SevaMob's Cancer Intervention (breast/prostate/cervical screening) and Niramai operate on the same playbook of AI-enabled screening delivered to underserved populations in India.
- SigTuple: India-based AI pathology and microscopy company automating analysis of blood, urine, and semen samples for diagnostic labs. Direct peer given the strong overlap with SevaMob's Blood AI (anemia screening via smartphone microscope) and Lab Report AI modules on the same imaging-AI and last-mile-diagnostics thesis.
- HealthifyMe: India- and SEA-based AI-driven nutrition and wellness platform with proprietary AI (Ria) for diet and lifestyle coaching, plus a B2B channel into employers and insurers. Direct peer because HealthifyMe's Diet AI / Ria and employer-channel approach directly parallels SevaMob's Diet AI module and employer customer segment.
- Ada Health: Berlin-based AI symptom-assessment and care-navigation platform sold to health systems, insurers, and employers globally. Direct peer given the strong overlap with SevaMob's Symptoms AI and Medical Evaluation AI modules on AI-driven triage and clinical decision support.
- K Health: US-based AI-powered primary care platform combining a chat-based symptom/triage model with virtual visits and chronic-condition management, distributed via employers and insurers. Direct peer for SevaMob's combination of AI triage with telehealth primary care, employer-sponsored contracts, and chronic-condition focus (cardiometabolic).
Broad incumbents
- Practo: India's largest consumer-facing digital health platform spanning teleconsultations, ePharmacy, and software for clinics and hospitals, with an enterprise/employer channel. Broad incumbent peer because it overlaps with SevaMob's telehealth and B2B employer/insurance segments but operates at significantly larger scale and across a broader portfolio of services.
- Tata 1mg (1mg): India's leading online pharmacy and diagnostic aggregator, now part of the Tata Group, with ePharmacy, teleconsultation, and lab-test booking. Broad incumbent peer because it overlaps with SevaMob's medicine-delivery and diagnostic-screening value proposition for B2B and B2C customers, though at materially greater scale.
Emerging players
- Biofourmis: Boston- and Singapore-based AI health analytics platform focused on remote monitoring and predictive care for chronic conditions, sold to health systems and pharma. Emerging player peer because Biofourmis shares SevaMob's AI-plus-monitoring thesis for chronic disease management but operates in higher-acuity, higher-cost settings rather than last-mile primary care.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks3 records
Key highlights7 records
Customer concentration
SevaMob social profiles
Digital presenceSevaMob financial estimates
Financial estimateRevenue estimate
Valuation estimate
SevaMob leadership team
Management profileNumber of profiles
Profiles4 records
SevaMob funding detail
Funding detailFunding overview
Funding rounds7 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SevaMob M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SevaMob
What does SevaMob do?
SevaMob provides an AI-enabled healthcare platform that combines proprietary point-of-care AI screening modules (Symptoms AI, Diet AI, Lab Report AI, Medical Evaluation AI, Blood AI, Vision AI, Sputum AI, Xray AI, Campaign AI) with tele-health consultations and asset-lite popup clinics to deliver primary health outcomes at the last mile. The company licenses its AI platform to B2B customers including employers, NGOs, hospitals, pharma companies, health insurers, and local government, and offers a Developer API (Seva360) for integration into web or mobile applications. Solutions are designed to work offline in low-resource settings with minimal training required for health workers.
Is SevaMob a public or private company?
SevaMob is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was SevaMob founded?
SevaMob was founded in 2013. It employs 51 to 100 people.
Where is SevaMob based?
SevaMob is headquartered in Decatur, United States, in the North America region.
How does SevaMob make money?
Two revenue lines are on record. Software Licensing is the primary driver. The others are health Outcome Delivery.
Who are SevaMob's main competitors?
Direct peers on record are Qure.ai, Tricog Health, Niramai Health Analytix, SigTuple, HealthifyMe, Ada Health and K Health. Broad incumbents are Practo and Tata 1mg (1mg). Biofourmis is listed as an emerging player.
Does SevaMob have an API?
Yes. REST API enabling developers to integrate Sevamob AI capabilities into web or mobile applications. Allows analysis of blood, vision, sputum and xray images with simple API calls. Developer documentation is at seva360.com.
What industry is SevaMob in?
SevaMob's product category is AI Healthcare Platform. Its primary akta.pro industry code is HLALADAD, Chronic Condition Management & Remote Monitoring (e.g., diabetes, HTN). Its NAICS code is 621498 and its SIC code is 8000.